4-chloro-3-hydroxyanthranilic acid has been researched along with norharman in 1 studies
| Studies (4-chloro-3-hydroxyanthranilic acid) | Trials (4-chloro-3-hydroxyanthranilic acid) | Recent Studies (post-2010) (4-chloro-3-hydroxyanthranilic acid) | Studies (norharman) | Trials (norharman) | Recent Studies (post-2010) (norharman) |
|---|---|---|---|---|---|
| 20 | 0 | 2 | 364 | 2 | 153 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Crowley, JS; Heyes, MP; Markey, SP; Masana, M; Saito, K | 1 |
1 other study(ies) available for 4-chloro-3-hydroxyanthranilic acid and norharman
| Article | Year |
|---|---|
4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Topics: 3-Hydroxyanthranilic Acid; Animals; Brain; Carbolines; Cell Line; Harmine; Humans; Interferon-gamma; Kynurenine; Leukocytes, Mononuclear; Macrophages; Quinolinic Acid; Rats; Tryptophan; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |